Suimon Yuka, Kase Satoru, Ishijima Kan, Kanno-Okada Hiromi, Ishida Susumu
Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan.
Department of Surgical Pathology, Hokkaido University Hospital, Sapporo 060-8638, Japan.
Int J Ophthalmol. 2018 Sep 18;11(9):1539-1544. doi: 10.18240/ijo.2018.09.18. eCollection 2018.
To investigate clinicopathological features of immunoglobulin G4-related ophthalmic disease (IgG4-ROD), and analyze the recurrence rates following systemic corticosteroid administration.
We retrospectively searched clinical features, laboratory and histological findings based on the medical records of 21 patients with IgG4-ROD. All the patients examined in this study underwent surgical resection in the ocular adnexal lesions and underwent histological evaluation. This study further investigated clinical and histopathological features of 15 patients who received systemic corticosteroid after the resection.
The mean age of the patients consisting of 7 males (33%) and 14 females (67%) was 61y. Fourteen patients were diagnosed as definitive, and 2 and 5 patients were probable and possible IgG4-ROD, respectively. Eyelid swelling was an initial symptom in 11 patients (52%) who did not show systemic involvements at a diagnosis. Fifteen patients received systemic corticosteroid administration, and all showed remission of inflammation. Among them, 10 patients did not recur, whereas 5 patients (33%) recurred during tapering. There were no significant difference between patients with or without recurrence in clinicopathological features.
In this study, female patients are more predominant in IgG4-ROD. While inflammation recurs in one-third of patients, this study do not identify factors associated with recurrence after systemic corticosteroid administration.
探讨免疫球蛋白G4相关性眼病(IgG4-ROD)的临床病理特征,并分析全身应用糖皮质激素后的复发率。
我们回顾性检索了21例IgG4-ROD患者的病历,分析其临床特征、实验室检查及组织学表现。本研究中所有接受检查的患者均接受了眼附属器病变的手术切除,并进行了组织学评估。本研究进一步调查了15例术后接受全身糖皮质激素治疗患者的临床和组织病理学特征。
患者平均年龄61岁,其中男性7例(33%),女性14例(67%)。14例患者被确诊为IgG4-ROD,2例和5例分别可能和疑似IgG4-ROD。11例患者(52%)以眼睑肿胀为首发症状,诊断时无全身受累表现。15例患者接受了全身糖皮质激素治疗,所有患者炎症均缓解。其中,10例患者未复发,5例患者(33%)在减药过程中复发。复发患者与未复发患者的临床病理特征无显著差异。
本研究中,IgG4-ROD以女性患者居多。虽然三分之一的患者炎症复发,但本研究未发现全身应用糖皮质激素后复发的相关因素。